Tofacitinib therapy for children with severe alopecia areata

[1]  B. King,et al.  Tofacitinib for the treatment of alopecia areata in preadolescent children. , 2019, Journal of the American Academy of Dermatology.

[2]  B. King,et al.  Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients , 2018, Journal of the American Academy of Dermatology.

[3]  L. Brichta,et al.  Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata , 2017, Journal of the American Academy of Dermatology.

[4]  B. King,et al.  Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients , 2017, Journal of the American Academy of Dermatology.

[5]  B. King,et al.  Tofacitinib for the treatment of alopecia areata and variants in adolescents , 2017, Journal of the American Academy of Dermatology.